Integrity Alliance LLC. Acquires Shares of 1,094 Intuitive Surgical, Inc. $ISRG

Key Points

• Integrity Alliance LLC has purchased 1,094 shares of Intuitive Surgical, Inc. valued at approximately $542,000 as part of its new investment in the company.
• Intuitive Surgical's stock has declined by 1.4%, trading at $449.68, having a market cap of $161.20 billion and a price-to-earnings ratio of 62.72.
• The company reported $2.19 earnings per share for the last quarter, exceeding analyst expectations, with a revenue of $2.44 billion, marking a 21.4% year-over-year increase.

Integrity Alliance LLC. acquired a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 1,094 shares of the medical equipment provider's stock, valued at approximately $542,000.

A number of other institutional investors have also modified their holdings of the company. Nuveen LLC acquired a new position in Intuitive Surgical during the first quarter worth approximately $1,715,899,000. GAMMA Investing LLC increased its position in Intuitive Surgical by 54,010.7% during the first quarter. GAMMA Investing LLC now owns 3,028,576 shares of the medical equipment provider's stock worth $14,999,630,000 after purchasing an additional 3,022,979 shares during the last quarter. Goldman Sachs Group Inc. increased its position in Intuitive Surgical by 26.1% during the first quarter. Goldman Sachs Group Inc. now owns 2,819,666 shares of the medical equipment provider's stock worth $1,396,496,000 after purchasing an additional 584,375 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its position in Intuitive Surgical by 20.1% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 3,393,951 shares of the medical equipment provider's stock worth $1,680,922,000 after purchasing an additional 566,979 shares during the last quarter. Finally, Wellington Management Group LLP increased its position in Intuitive Surgical by 15.0% during the first quarter. Wellington Management Group LLP now owns 3,499,052 shares of the medical equipment provider's stock worth $1,732,975,000 after purchasing an additional 457,080 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company's stock.

Analyst Upgrades and Downgrades

Several equities analysts recently commented on ISRG shares. Wells Fargo & Company upped their price target on shares of Intuitive Surgical from $559.00 to $599.00 and gave the stock an "overweight" rating in a research report on Wednesday, July 23rd. Wall Street Zen raised shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a research report on Saturday, July 26th. Erste Group Bank reaffirmed a "hold" rating on shares of Intuitive Surgical in a research report on Wednesday, July 23rd. Royal Bank Of Canada reaffirmed an "outperform" rating and set a $615.00 price target on shares of Intuitive Surgical in a research report on Tuesday, August 19th. Finally, Truist Financial increased their price objective on shares of Intuitive Surgical from $590.00 to $600.00 and gave the stock a "buy" rating in a research report on Wednesday, July 23rd. Thirteen research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $595.95.

Intuitive Surgical Stock Performance

Shares of ISRG stock traded down $15.69 on Monday, hitting $433.99. The stock had a trading volume of 3,471,134 shares, compared to its average volume of 2,153,700. The firm has a market capitalization of $155.58 billion, a price-to-earnings ratio of 60.53, a P/E/G ratio of 4.71 and a beta of 1.61. The stock's 50 day moving average is $483.65 and its 200-day moving average is $506.85. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, beating the consensus estimate of $1.93 by $0.26. The business had revenue of $2.44 billion during the quarter, compared to the consensus estimate of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The business's quarterly revenue was up 21.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.78 earnings per share. Equities analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Activity

In other news, Director Amy L. Ladd sold 336 shares of the company's stock in a transaction on Wednesday, September 3rd. The shares were sold at an average price of $470.11, for a total value of $157,956.96. Following the completion of the transaction, the director directly owned 1,074 shares in the company, valued at approximately $504,898.14. This represents a 23.83% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Myriam Curet sold 4,500 shares of the company's stock in a transaction on Friday, July 25th. The shares were sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the completion of the transaction, the executive vice president owned 353 shares of the company's stock, valued at $173,845.44. This trade represents a 92.73% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 45,224 shares of company stock worth $21,716,492. 0.70% of the stock is currently owned by company insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.